Illustrating the structural diversity of SARS-CoV-2 Omicron spike

NewsGuard 100/100 Score

In a recent study posted to the bioRxiv* pre-print server, a team of researchers used cryo-electron microscopy (cryo-EM) to determine the spike (S) structures of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant to understand how the mutations that alter its primary sequence impact S conformation.

Study: Structural diversity of the SARS-CoV-2 Omicron spike. Image Credit: Naeblys/ShutterstockStudy: Structural diversity of the SARS-CoV-2 Omicron spike. Image Credit: Naeblys/Shutterstock

The Omicron S protein has mutations in its receptor-binding S1-subunit and its fusion subunit S2. The S2 subunit is conformationally stable before the receptor binding event; the S1 subunit, on the other hand, with its mobile N-terminal domain (NTD) and receptor-binding domain (RBD), is innately predisposed to conformational changes.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The RBD transitions between a closed (down) state where the angiotensin-converting enzyme 2 (ACE2) binding site is blocked and an open (up) states that exposes the ACE2 biding site. Following receptor binding and proteolytic processing, the S2 subunit undergoes conformational changes that release the fusion peptide (FP) to mediate the fusion of the virus and host-cell membranes. 

In addition, RBD dynamics are impacted by interprotomer RBD-to-RBD and RBD-to-NTD contacts by the SD1 and SD2 subdomains and the “N2R (NTD-to-RBD) linker” within a protomer.

Structural studies using an S-GSAS platform that did not contain any extraneous stabilizing mutations in the S2 subunit helped visualize S protein conformations in its native format and illustrate a diverse repertoire of structural states of the Omicron S.

About the study

Previously, the authors of this study had described how SARS-CoV-2 variants of concern (VOCs) modulate the S1 subunit interactions to alter the S protein RBD presentation and ways to exploit the same for immunogen design.

In the present study, the researchers determined the native Omicron and Delta S proteins to understand how mutations alter the conformational states and influence S RBD and antibody (Ab) epitope presentation.  

More specifically, they determined structures of 3-RBD-down, 1-RBD-up, and 2-RBD-up populations of the Omicron and Delta S ectodomains.

Findings

The domain organization of Omicron S was significantly different compared to other variants, as observed in the structural studies, and quantified using sets of intra- and inter-protomer vectors. 

The Omicron S protein displayed reduced S1 variability with many of its 16 immune-evasive RBD amino acid mutations stabilizing the RBD-RBD interfaces, which also stabilized 1-RBD-up states in a manner not observed in the Delta S. Omicron S showed a closely packed RBD-RBD interface in the 3-RBD-down conformation distinct from the other SARS-CoV-2 variants and an RBD loop harboring the S371L, S373P and S375F mutations in one protomer mediated new interprotomer interactions, and a Y505H mutation was observed in the adjacent interacting protomer. This rearrangement was also identified in the Delta VOC and other variants but was comparatively rare in them. 

SARS-CoV-2 VOCs that dominated before Omicron, such as the Delta variant, maximized transmissibility by favoring open-S states and mutated Ab epitopes for immune evasion. Omicron’s S acquired RBD-down state stabilizing mutations that sealed highly immunogenic sites that bound potent Abs bolstered its immune-evasion ability. 

In addition, the authors speculated that structurally, Omicron S could have achieved high transmissibility by taking one of the two routes. First, locking down the mobile RBDs would have resulted in a metastable S with rearrangements in the peptide N2R linker (connecting the NTD and RBD in a protomer). Second, the researchers combined binding assays, X-ray crystallography, and cryo-EM to unveil altered plasticity of the FP in the Omicron S compared to other variants, including Delta. Despite extensive stabilization, the functionally critical FP of the Omicron S was more easily exposed.  

Relative to the Delta S, a weaker binding of Omicron S protein to 2G12 and other Fabdimerized glycan-reactive (FDG) Abs that targeted a quaternary S2 glycan cluster, as well as by enhanced binding to FP directed Ab DH1058, suggested altered S2 conformational dynamics. A high-resolution crystal structure of the FP-Ab complex suggested enhanced FP dynamics may be associated with Omicron’s increased transmissibility. 

Conclusions 

The increased Omicron transmissibility could be due to the combined effect of the ease of accessing the RBD-up state, sustained affinity for ACE2 interactions despite multiple mutations in the RBD region, and the more ready release of the FP. The results also indicated the Omicron S evolved beyond immune evasion toward a compact architecture with well-regulated fusion machinery and altered FP dynamics.

To conclude, future studies should closely monitor the continued evolution of the structure of future variants on the Omicron template to achieve a deep understanding of Omicron biology and in anticipation of the immune escape potential of the future VOCs.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • May 11 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Neha Mathur

Written by

Neha Mathur

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Mathur, Neha. (2023, May 11). Illustrating the structural diversity of SARS-CoV-2 Omicron spike. News-Medical. Retrieved on April 23, 2024 from https://www.news-medical.net/news/20220201/Illustrating-the-structural-diversity-of-SARS-CoV-2-Omicron-spike.aspx.

  • MLA

    Mathur, Neha. "Illustrating the structural diversity of SARS-CoV-2 Omicron spike". News-Medical. 23 April 2024. <https://www.news-medical.net/news/20220201/Illustrating-the-structural-diversity-of-SARS-CoV-2-Omicron-spike.aspx>.

  • Chicago

    Mathur, Neha. "Illustrating the structural diversity of SARS-CoV-2 Omicron spike". News-Medical. https://www.news-medical.net/news/20220201/Illustrating-the-structural-diversity-of-SARS-CoV-2-Omicron-spike.aspx. (accessed April 23, 2024).

  • Harvard

    Mathur, Neha. 2023. Illustrating the structural diversity of SARS-CoV-2 Omicron spike. News-Medical, viewed 23 April 2024, https://www.news-medical.net/news/20220201/Illustrating-the-structural-diversity-of-SARS-CoV-2-Omicron-spike.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study shows slight increase in Guillain-Barre syndrome risk with adenovirus COVID vaccines